Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis.

Cell | 2017

The recent discovery that genetically modified α cells can regenerate and convert into β-like cells in vivo holds great promise for diabetes research. However, to eventually translate these findings to human, it is crucial to discover compounds with similar activities. Herein, we report the identification of GABA as an inducer of α-to-β-like cell conversion in vivo. This conversion induces α cell replacement mechanisms through the mobilization of duct-lining precursor cells that adopt an α cell identity prior to being converted into β-like cells, solely upon sustained GABA exposure. Importantly, these neo-generated β-like cells are functional and can repeatedly reverse chemically induced diabetes in vivo. Similarly, the treatment of transplanted human islets with GABA results in a loss of α cells and a concomitant increase in β-like cell counts, suggestive of α-to-β-like cell conversion processes also in humans. This newly discovered GABA-induced α cell-mediated β-like cell neogenesis could therefore represent an unprecedented hope toward improved therapies for diabetes.

Pubmed ID: 27916274 RIS Download

Additional research tools detected in this publication

None found

Antibodies used in this publication

Associated grants

None

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Mouse Osteopontin (OPN) Affinity Purified Polyclonal Ab (antibody)

RRID:AB_2194992

This polyclonal targets Mouse Osteopontin (OPN) Affinity Purified Ab

View all literature mentions

RABBIT IGG FRACTION TO β-GALACTOSIDASE (antibody)

RRID:AB_2335269

This unknown targets RABBIT IGG FRACTION TO β-GALACTOSIDASE

View all literature mentions

Anti-Prohormone Convertase PC1/PC3 (antibody)

RRID:AB_1977441

This polyclonal targets Prohormone Convertase PC1/PC3

View all literature mentions

Anti-NeuroD 1 (antibody)

RRID:AB_805388

This unknown targets NeuroD1

View all literature mentions

Anti-GLUT-2 (antibody)

RRID:AB_1587076

This polyclonal targets GLUT-2

View all literature mentions

Anti-Somatostatin Antibody, clone YC7 (antibody)

RRID:AB_2255365

This monoclonal targets Somatostatin

View all literature mentions

E-Cadherin (antibody)

RRID:AB_397581

This monoclonal targets E-Cadherin

View all literature mentions

Anti-Bromodeoxyuridine Antibody, Fluorescein Conjugated (antibody)

RRID:AB_514484

This unknown targets Bromodeoxyuridine Fluorescein

View all literature mentions

Glucagon (D16G10) XP Rabbit mAb (antibody)

RRID:AB_10859908

This monoclonal targets Glucagon (D16G10) XP Rabbit mAb

View all literature mentions

Insulin (antibody)

RRID:AB_10013624

This polyclonal targets Porcine pancreatic insulin

View all literature mentions

Fiji (software resource)

RRID:SCR_002285

Software package as distribution of ImageJ and ImageJ2 together with Java, Java3D and plugins organized into coherent menu structure. Used to assist research in life sciences.

View all literature mentions

GraphPad Prism (software resource)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions